MEDPLUS logo

Medplus Health SERV LTD

MEDPLUS·NSE·
₹611.10▼ -1.70 (-0.28%)
Market Cap7351.79 Cr
PE Ratio33.34
Volume29,856
Day High - Low615.00 - 608.80
52W High-Low1022.20 - 608.80

Medplus Health Serv Ltd (MEDPLUS): company summary

The company's business is improving, with annual revenue rising 12.3% and net profit growing 46.4% year-over-year.

Medplus Health Serv Ltd (MEDPLUS) is a small-cap Consumer Services company valued at ₹7,352 crore operating in Pharmacy Retail on the NSE and BSE.

Recent price move
Medplus Health Serv Ltd last traded at ₹611.1, modestly down 0.28% on the day.
Recent developments
On 2026-06-30, the company reported its latest quarter results, showing revenue of ₹1,880 crore and net profit of ₹33 crore. Promoter shares pledged increased to 60.74% of promoter holding, indicating potential liquidity concerns. Foreign institutional holding decreased by 1.15 percentage points, while domestic institutional holding rose by 2.13 percentage points.
Financial performance
The company's business is improving, with annual revenue rising 12.3% and net profit growing 46.4% year-over-year. However, the latest quarter saw net profit fall 21.0% compared to the same quarter a year earlier, despite revenue increasing 21.8%.
Valuation multiples
The stock trades at 33.3 times earnings, 4.01 times book value.
Things to watch
The company's net profit margin has narrowed from 2.4% to 3.2%, though it has improved by 0.7 percentage points. Promoter shares pledged account for 60.74% of promoter holding, which may signal financial pressure. The stock is 36.0% below its 52-week high, indicating a significant correction from recent peak levels.
Where it stands
The company has shown strong revenue growth over the past five years, with a 28.4% profit CAGR, but recent quarterly results show a decline in net profit. The stock is currently 36.0% below its 52-week high, and promoter shares pledged represent a significant portion of holdings. The most recent figure is the latest quarter net profit of ₹33 crore.

Summarised by DocStoX's model on 2026-10-03 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.

DocStoX Score
4.3/10
Weak
Fair Value
Sign in to see
ROE
11.12%
Average
P/E
33.34x
Fair
Debt / Equity
0.72
Moderate
Industry
Consumer Services
Pharmacy Retail
Overall View
Mixed

Price performance

Day₹608.80
₹615.00
52W₹608.80
₹1022
DocStoX take

Supported by growth (7.8) and risk (6.4), but held back by momentum (0.0). Growth looks strong at 7.8, but that is offset by momentum at 0.0 and valuation at 1.8. We are calling it Mixed rather than resolving the conflict for you.

DocStoX score

Low confidence
4.3
/10
Weak
Quality
Modest
ROE 11.1%
Valuation
Expensive
P/E 33.3×
Growth
Strong
Revenue +17.6% 5Y CAGR
Risk
Moderate
D/E 0.72
Momentum
Weak
1% of 52-week range

At a glance

Market Cap
₹7,352 Cr
52W High / Low
₹1022 / ₹609
Dividend Yield
0.00%
Promoter Holding
40.19%
EPS (TTM)
₹18.33
Book Value
₹164.54

Key highlights

  • Profit compounding 28% a year
  • Profitable in all of the last 5 years
  • Revenue compounding 18% a year
  • 74% of promoter holding is pledged
  • Valuation is weak (1.8/10)
3 Positives4 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Consumer Services stocks · Pharmacy Retail

MEDPLUS HEALTH SERV LTD peers in Consumer Services

Other Consumer Services stocks on the NSE & BSE. See the full Consumer Services sector list.